• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

    7/6/23 10:30:53 AM ET
    $ACHR
    $AEMD
    $AFRM
    $ALLR
    Aerospace
    Industrials
    Medical/Dental Instruments
    Health Care
    Get the next $ACHR alert in real time by email

    Gainers

    • Caribou Biosciences, Inc. (NASDAQ:CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer.
    • Mullen Automotive, Inc. (NASDAQ:MULN) shares climbed 53.1% to $ 0.2616 fter the company on Wednesday announced the retention of a law group to investigate possible naked short selling. The company also announced a buyback on Thursday.
    • T2 Biosystems, Inc. (NASDAQ:TTOO) gained 27.5% to $0.0944. T2 Biosystems announced the conversion of approximately 20% of its term loan with entities affiliated with CRG Servicing LLC into its common stock and Series B convertible preferred stock.
    • Borqs Technologies, Inc. (NASDAQ:BRQS) jumped 23.5% to $0.1915. Borqs Technologies and SkyCentrics will start commercial shipment of next generation CTA-2045 ECOPORT Smart Control Products in the third quarter.
    • Micromobility.com Inc. (NASDAQ:MCOM) shares rose 16.8% to $0.1321. micromobility.com recently announced a strategic realignment to strengthen its financial position and drive profitability.
    • Genius Sports Limited (NYSE:GENI) gained 14.2% to $6.63 after the company agreed to a multi-year extension of the National Football League partnership.
    • Aethlon Medical, Inc. (NASDAQ:AEMD) rose 13.7% to $0.3865. The company recent posted a narrower fourth-quarter loss.
    • Aurora Mobile Limited (NASDAQ:JG) gained 12.1% to $0.2756. Aurora Mobile secured approval to transfer to Nasdaq Capital Market.
    • Barnes & Noble Education, Inc. (NYSE:BNED) rose 11.2% to $1.8250.
    • Sweetgreen, Inc. (NYSE:SG) shares climbed 10.8% to $14.44 after B of A Securities upgraded the stock from Neutral to Buy and raised its price target from $9 to $17.
    • urban-gro, Inc. (NASDAQ:UGRO) gained 10.6% to $1.3490.
    • The Children's Place, Inc. (NASDAQ:PLCE) rose 10.4% to $26.31.
    • Minim, Inc. (NASDAQ:MINM) gained 9.3% to $4.95.
    • Holley Inc. (NYSE:HLLY) rose 7% to $4.0550. Canaccord Genuity maintained Holley with a Buy and raised the price target from $5 to $6.
    • Perion Network Ltd. (NASDAQ:PERI) shares climbed 6.6% to $32.91 following preliminary results for the second quarter. The company expects to report revenues of $176.0 million (+20% Y/Y) vs. consensus of $169.88 million and adjusted EBITDA of $40.0 million (+40% Y/Y), with adjusted EBITDA-to-revenue of 23%.

    Losers

    • Allarity Therapeutics, Inc. (NASDAQ:ALLR) shares fell 53% to $3.89 after the company priced its public offering of 2.44 million shares and warrants to purchase up to 2.44 million shares at combined price of $4.50.
    • VBI Vaccines Inc. (NASDAQ:VBIV) fell 52% to $1.1393. VBI Vaccines reported pricing of $18 million public offering and $3 million concurrent registered direct offering. VBI Vaccines and Brii Biosciences also announced the expansion of their hepatitis B partnership.
    • ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) fell 23.8% to $2.92 after the company said the eblasakimab 400mg Q4W dosing arm did not meet the primary or secondary endpoints with statistical significance.
    • Nymox Pharmaceutical Corporation (NASDAQ:NYMX) fell 23.1% to $0.1914 after the company received a Nasdaq Hearing Delist Decision, noting that Nymox has not regained the required $1.00 share price within the 6-month extension period granted by Nasdaq, and hence the company's shares will be suspended from trading on NASDAQ at the open of business on July 7, 2023.
    • iMedia Brands, Inc. (NASDAQ:IMBI) dropped 19.3% to $0.1251.
    • 22nd Century Group, Inc. (NASDAQ:XXII) fell 18.8% to $3.05. 22nd Century announced a $3 million registered direct offering priced above market.
    • ALX Oncology Holdings Inc. (NASDAQ:ALXO) fell 17% to $6.05.
    • Freight Technologies, Inc. (NASDAQ:FRGT) dipped 16% to $0.9242.
    • Cybin Inc. (NASDAQ:CYBN) fell 15.1% to $0.4158.
    • MyMD Pharmaceuticals, Inc. (NASDAQ:MYMD) dropped 15% to $1.1899.
    • Spark Networks SE (NASDAQ:LOV) dipped 14.6% to $0.4109.
    • Nuburu, Inc. (NYSE:BURU) fell 14.4% to $0.5499.
    • Applied Digital Corporation (NASDAQ:APLD) dropped 14.1% to $7.71. Wolf Pack Research out with short report on the company titled "APLD: An Embarrassing And Predictable Stock Promotion."
    • Affirm Holdings, Inc. (NASDAQ:AFRM) declined 14% to $13.26 after Piper Sandler downgraded the stock from Neutral to Underweight.
    • Tattooed Chef, Inc. (NASDAQ:TTCF) fell 12.7% to $0.2505. Tattooed Chef recently announced it intends to file for voluntary Chapter 11 Bankruptcy protection.
    • Offerpad Solutions Inc. (NYSE:OPAD) dropped 11.6% to $11.15. Offerpad Solutions said that Jawad Ahsan will become Chief Financial Officer of the company effective July 10, succeeding Michael Burnett, who will remain with the company in an advisory capacity through Aug. 1.
    • Calliditas Therapeutics AB (NASDAQ:CALT) fell 11% to $15.85 after gaining around 13% on Wednesday.
    • Aurora Innovation, Inc. (NASDAQ:AUR) declined 10% to $2.7993.
    • Archer Aviation Inc. (NYSE:ACHR) dropped 9.4% to $4.39. Canaccord Genuity reiterated Archer Aviation with a Buy and maintained a $9 price target.
    • Upstart Holdings, Inc. (NASDAQ:UPST) fell 8.4% to $35.60. The stock is potentially falling in sympathy with peer digital lending platform Affirm Holdings. Piper Sandler analyst Kevin Barker on Thursday downgraded Affirm from Neutral to Underweight and announced an $11 price target.
    • Wayfair Inc. (NYSE:W) fell 7.7% to $58.93.
    • Rackspace Technology, Inc. (NASDAQ:RXT) dropped 7.2% to $2.2697.

     

    Now Read This: Top 5 Energy Stocks That May Crash In July

    Get the next $ACHR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACHR
    $AEMD
    $AFRM
    $ALLR

    CompanyDatePrice TargetRatingAnalyst
    Sweetgreen Inc.
    $SG
    3/30/2026$4.50Mkt Underperform
    Citizens
    Perion Network Ltd.
    $PERI
    3/20/2026$14.00Buy
    Canaccord Genuity
    ALX Oncology Holdings Inc.
    $ALXO
    3/19/2026$5.00Overweight
    Wells Fargo
    Upstart Holdings Inc.
    $UPST
    3/16/2026$43.00Neutral → Buy
    BTIG Research
    Sweetgreen Inc.
    $SG
    3/9/2026Peer Perform
    Wolfe Research
    ALX Oncology Holdings Inc.
    $ALXO
    3/6/2026$6.00Buy
    UBS
    Sweetgreen Inc.
    $SG
    3/6/2026$5.50Neutral
    DA Davidson
    Affirm Holdings Inc.
    $AFRM
    3/5/2026$82.00Buy
    BofA Securities
    More analyst ratings

    $ACHR
    $AEMD
    $AFRM
    $ALLR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Concept Officer Jammet Nicolas bought $25,284 worth of shares (4,428 units at $5.71) (SEC Form 4)

    4 - Sweetgreen, Inc. (0001477815) (Issuer)

    3/9/26 5:55:54 PM ET
    $SG
    Restaurants
    Consumer Discretionary

    Director Goodman Corey S bought $4,999,999 worth of shares (3,184,713 units at $1.57) (SEC Form 4)

    4 - ALX ONCOLOGY HOLDINGS INC (0001810182) (Issuer)

    2/4/26 4:15:59 PM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Executive Officer Urmson Christopher bought $1,000,627 worth of shares (258,000 units at $3.88) (SEC Form 4)

    4 - Aurora Innovation, Inc. (0001828108) (Issuer)

    11/26/25 9:09:12 AM ET
    $AUR
    EDP Services
    Technology

    $ACHR
    $AEMD
    $AFRM
    $ALLR
    SEC Filings

    View All

    SEC Form 6-K filed by Freight Technologies Inc.

    6-K - Freight Technologies, Inc. (0001687542) (Filer)

    4/7/26 6:40:01 AM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    urban-gro Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - urban-gro, Inc. (0001706524) (Filer)

    4/6/26 8:30:47 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    Rackspace Technology Inc. filed SEC Form 8-K: Leadership Update

    8-K - Rackspace Technology, Inc. (0001810019) (Filer)

    4/3/26 4:08:40 PM ET
    $RXT
    Computer Software: Programming Data Processing
    Technology

    $ACHR
    $AEMD
    $AFRM
    $ALLR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citizens initiated coverage on Sweetgreen with a new price target

    Citizens initiated coverage of Sweetgreen with a rating of Mkt Underperform and set a new price target of $4.50

    3/30/26 8:21:21 AM ET
    $SG
    Restaurants
    Consumer Discretionary

    Canaccord Genuity initiated coverage on Perion Network with a new price target

    Canaccord Genuity initiated coverage of Perion Network with a rating of Buy and set a new price target of $14.00

    3/20/26 8:36:30 AM ET
    $PERI
    EDP Services
    Technology

    Wells Fargo initiated coverage on ALX Oncology with a new price target

    Wells Fargo initiated coverage of ALX Oncology with a rating of Overweight and set a new price target of $5.00

    3/19/26 8:25:33 AM ET
    $ALXO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $AEMD
    $AFRM
    $ALLR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    22nd Century Advances Reduced Nicotine Product to Target Approximately Half of the ~$82 Billion U.S. Cigarette Market with 100mm VLN® Product Initiative

    Company to Pursue Additional PMTA Submissions, Building on Its Status as the Only Holder of an FDA-Authorized Low Nicotine Combustible Cigarette Branded as VLN® Products Expanded PMTA Portfolio and Licensing Strategy Designed to Address Wider Consumer Preference and Unlock Further Retail Penetration Opportunities MOCKSVILLE, N.C., April 07, 2026 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NASDAQ:XXII), a tobacco products company focused on reducing the harms of smoking through nicotine reduction, today announced an update on the advancement of a 100mm VLN® reduced nicotine content cigarette. The Company's proprietary reduced nicotine technology is designed to serve adult smokers who w

    4/7/26 8:00:00 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    Wayfair Announces First Florida Store in Fort Lauderdale, Opening in 2027

    New location at Galleria Fort Lauderdale will be part of the center's major redevelopmentBOSTON, April 7, 2026 /PRNewswire/ -- Wayfair Inc. (NYSE:W), the destination for all things home, today announced it will open its first large-format store in Florida at Galleria Fort Lauderdale, as part of the center's comprehensive redevelopment. Scheduled to open in late 2027, the new location will span approximately 94,000 square feet across two levels, marking a significant milestone in Wayfair's continued physical retail expansion. "As we continue to grow our retail footprint, entering

    4/7/26 7:00:00 AM ET
    $W
    Catalog/Specialty Distribution
    Consumer Discretionary

    Freight Technologies Launches DODA Smart, an AI-Powered Customs Compliance Platform for Mexican Trade Operators

    HOUSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Freight Technologies, Inc. (NASDAQ:FRGT, "Fr8Tech" or the "Company")), a technology-centric logistics company offering a diversified portfolio of AI software solutions designed to address key inefficiencies in the supply chain, today announced the commercial launch of DODA Smart, an AI-powered platform to automatically verify, monitor, and trace the full lifecycle management of Digital Customs Documents ("DODAs") for customs agencies, freight forwarders, carriers, and import-exporters operating across the U.S.–México corridor. The platform is designed to synchronize automatically with the México Tax Administration Service (Servicio de Administrac

    4/7/26 6:30:00 AM ET
    $FRGT
    Professional Services
    Consumer Discretionary

    $ACHR
    $AEMD
    $AFRM
    $ALLR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Vorhaus Michael

    4 - Perion Network Ltd. (0001338940) (Issuer)

    4/6/26 8:06:14 AM ET
    $PERI
    EDP Services
    Technology

    SEC Form 4 filed by Marcus Joy Sharon

    4 - Perion Network Ltd. (0001338940) (Issuer)

    4/6/26 8:02:51 AM ET
    $PERI
    EDP Services
    Technology

    SEC Form 4 filed by Kaplan Eyal

    4 - Perion Network Ltd. (0001338940) (Issuer)

    4/6/26 7:08:28 AM ET
    $PERI
    EDP Services
    Technology

    $ACHR
    $AEMD
    $AFRM
    $ALLR
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 23, 2021 - FDA Authorizes Marketing of Tobacco Products that Help Reduce Exposure to and Consumption of Nicotine for Smokers Who Use Them

    For Immediate Release: December 23, 2021 Today, the U.S. Food and Drug Administration authorized the marketing of 22nd Century Group Inc.’s “VLN King” and “VLN Menthol King” combusted, filtered cigarettes as modified risk tobacco products (MRTPs), which help reduce exposure to, and consumption of, nicotine for smokers who use them. These are the first combusted cigarettes to be authorized as MRTPs and the second

    12/23/21 9:06:12 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    FDA Approval for TARPEYO issued to CALLIDITAS THERAPEUTICS AB

    Submission status for CALLIDITAS THERAPEUTICS AB's drug TARPEYO (ORIG-1) with active ingredient BUDESONIDE has changed to 'Approval' on 12/15/2021. Application Category: NDA, Application Number: 215935, Application Classification: Type 5 - New Formulation or New Manufacturer

    12/20/21 3:40:41 PM ET
    $CALT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACHR
    $AEMD
    $AFRM
    $ALLR
    Leadership Updates

    Live Leadership Updates

    View All

    Samsara to Accelerate the Future of Physical AI at HumanX 2026

    Aurora, Semafor, and Serve Robotics to join Samsara for a masterclass on the mixed-autonomy revolution Samsara (NYSE:IOT), the pioneer of the Connected Operations Platform, today announced it will participate in HumanX 2026, the world's premier AI conference. On Wednesday, April 8, 2026, at the Moscone Center, Samsara is defining the next frontier of physical AI—the integration of artificial intelligence into the physical systems that power the world's infrastructure. Serving as a crucial orchestration layer between autonomous vehicles (AVs), robotics, and human-led operations, Samsara is showcasing how it provides a unifying view of the complex ecosystem where human operators, autonomous

    3/31/26 9:00:00 AM ET
    $AUR
    $IOT
    $SERV
    EDP Services
    Technology
    Industrial Specialties
    Consumer Discretionary

    Barnes & Noble Education Reports Fiscal Third Quarter 2026 Financial Results

    BNC First Day Program Revenue Increases 32.1% Net Income of $6.7 Million and Adjusted EBITDA of $23.6 Million Company to Commence Dividend Program in First Quarter of Fiscal 2027 Virtual Investor Day Scheduled for June 25, 2026 FLORHAM PARK, N.J., March 10, 2026 (GLOBE NEWSWIRE) -- Barnes & Noble Education, Inc. (NYSE:BNED), ("Barnes & Noble Education," "BNED," "the Company," "we," "us," "our"), a leading solutions provider for the education industry, today reported financial results for the fiscal third quarter ended January 31, 2026. Virtual Investor Day Barnes & Noble Education has scheduled a virtual investor day for June 25, 2026. Management will provide an overview of the Com

    3/10/26 4:15:00 PM ET
    $BNED
    Other Specialty Stores
    Consumer Discretionary

    Aethlon Medical to Present on the Emerging Growth Conference on February 25th 2026

    Aethlon invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation on the Emerging Growth Conference.SAN DIEGO, Feb. 23, 2026 /PRNewswire/ -- Aethlon Medical, Inc. (the Company or Aethlon) (NASDAQ:AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, is pleased to announce that it has been invited to present on the Emerging Growth Conference on February 25, 2026 at 12:30-1:00 PM ET. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company's CEO and CFO, Jim Frakes in

    2/23/26 8:01:00 AM ET
    $AEMD
    Medical/Dental Instruments
    Health Care

    $ACHR
    $AEMD
    $AFRM
    $ALLR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Caribou Biosciences Inc.

    SC 13D/A - Caribou Biosciences, Inc. (0001619856) (Subject)

    12/6/24 4:06:56 PM ET
    $CRBU
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by Cybin Inc.

    SC 13G - CYBIN INC. (0001833141) (Subject)

    12/3/24 5:23:26 PM ET
    $CYBN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by 22nd Century Group Inc.

    SC 13G/A - 22nd Century Group, Inc. (0001347858) (Subject)

    12/3/24 11:18:54 AM ET
    $XXII
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACHR
    $AEMD
    $AFRM
    $ALLR
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at urban-gro Inc. on Jun 6

    Urban-gro Inc. saw an interesting insider purchase on June 6, 2024, when Wilks Lewis bought $29,000 worth of shares, acquiring 20,000 units at a price of $1.45 per unit. This transaction increased Lewis' direct ownership by 12% to 184,108 units, as reported in SEC Form 4. Insider transactions like this can provide valuable insights for investors, indicating confidence in the company's future prospects. Analyzing the insider activity surrounding Urban-gro Inc., we can observe several transactions that may reveal patterns or insights. Looking back at previous filings, on September 1, 2023, Wilks Lewis purchased $10,300 worth of shares, acquiring 10,000 units at $1.03 per unit. This

    6/10/24 12:49:49 AM ET
    $UGRO
    Industrial Specialties
    Consumer Discretionary

    $ACHR
    $AEMD
    $AFRM
    $ALLR
    Financials

    Live finance-specific insights

    View All

    Upstart to Announce First Quarter 2026 Results on May 5, 2026

    Upstart Holdings, Inc. (NASDAQ:UPST), the leading artificial intelligence (AI) lending marketplace, will hold a conference call to discuss its first quarter 2026 financial results on Tuesday, May 5, 2026, at 1:30 p.m. PT / 4:30 p.m. ET. The company's earnings press release and investor presentation will be available on its investor relations website at ir.upstart.com after the market closes that day. Live webcast. The live webcast and a replay will be available on Upstart's investor relations website. Conference Call Dial-In. To access the live conference call in the United States and Canada: 800-330-6710, conference code 7983833. To access the live conference call outside of the United

    4/6/26 4:05:00 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    Wayfair Schedules First Quarter 2026 Earnings Release and Conference Call

    BOSTON, April 2, 2026 /PRNewswire/ -- Wayfair Inc. (NYSE:W), the destination for all things home, today announced it will release financial results for its first quarter ending March 31, 2026 before the opening of the market on April 30, 2026. Wayfair will host a conference call at 8 a.m. ET on Thursday, April 30 to review results. Investors and participants can register for the webcast in advance here.The call will also be available via dial-in here. The archived webcast will be available shortly after the call at https://investor.wayfair.com.About WayfairWayfair is the destina

    4/2/26 7:00:00 AM ET
    $W
    Catalog/Specialty Distribution
    Consumer Discretionary

    Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress

         Strengthened financial position through disciplined cost management, with a year-end 2025 cash position of $14.7 million and runway into mid-2028Received FDA Fast Track designation for stenoparib, enabling accelerated development in advanced ovarian cancerDurable clinical benefit observed in ongoing stenoparib ovarian cancer study, including patients treated for nearly 30 months, with new Phase 2 protocol implementedExpansion of stenoparib development beyond ovarian cancer with the launch of a VA-funded Phase 2 combination study in recurrent small cell lung cancer TARPON SPRINGS, Fla., March 31, 2026 – Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a Phase 2

    3/31/26 8:00:00 AM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care